Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 3
2003 12
2004 10
2005 5
2006 9
2007 7
2008 7
2009 5
2010 4
2011 3
2012 4
2013 2
2014 5
2015 6
2016 3
2017 3
2018 7
2019 4
2020 10
2021 3
2022 5
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

101 results

Results by year

Filters applied: . Clear all
Page 1
Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials.
Harrison SA, Wong VW, Okanoue T, Bzowej N, Vuppalanchi R, Younes Z, Kohli A, Sarin S, Caldwell SH, Alkhouri N, Shiffman ML, Camargo M, Li G, Kersey K, Jia C, Zhu Y, Djedjos CS, Subramanian GM, Myers RP, Gunn N, Sheikh A, Anstee QM, Romero-Gomez M, Trauner M, Goodman Z, Lawitz EJ, Younossi Z; STELLAR-3; STELLAR-4 Investigators. Harrison SA, et al. J Hepatol. 2020 Jul;73(1):26-39. doi: 10.1016/j.jhep.2020.02.027. Epub 2020 Mar 6. J Hepatol. 2020. PMID: 32147362 Clinical Trial.
Liver abscess.
Tomimori K, Nakasone H, Hokama A, Nakayoshi T, Sakugawa H, Kinjo F, Shiraishi M, Nishimaki T, Saito A. Tomimori K, et al. Among authors: sakugawa h. Gastrointest Endosc. 2004 Mar;59(3):397-8. doi: 10.1016/s0016-5107(03)02590-2. Gastrointest Endosc. 2004. PMID: 14997139 No abstract available.
Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2014 to 2018 in Japan: A large-scale multicenter retrospective study.
Fujii H, Suzuki Y, Sawada K, Tatsuta M, Maeshiro T, Tobita H, Tsutsumi T, Akahane T, Hasebe C, Kawanaka M, Kessoku T, Eguchi Y, Syokita H, Nakajima A, Kamada T, Yoshiji H, Kawaguchi T, Sakugawa H, Morishita A, Masaki T, Ohmura T, Watanabe T, Kawada N, Yoda Y, Enomoto N, Ono M, Fuyama K, Okada K, Nishimoto N, Ito YM, Kamada Y, Takahashi H, Sumida Y; Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD). Fujii H, et al. Among authors: sakugawa h. Hepatol Res. 2023 Nov;53(11):1059-1072. doi: 10.1111/hepr.13947. Epub 2023 Aug 28. Hepatol Res. 2023. PMID: 37537735
"Whirl sign" of primary small bowel volvulus.
Tamura J, Kuniyoshi N, Maruwaka S, Shiroma J, Miyagi S, Orita H, Sakugawa H, Hokama A, Kinjo F, Fujita J. Tamura J, et al. Among authors: sakugawa h. West J Emerg Med. 2014 Jul;15(4):359-60. doi: 10.5811/westjem.2014.4.20679. West J Emerg Med. 2014. PMID: 25035728 Free PMC article. No abstract available.
Molecular tracing of Japan-indigenous hepatitis E viruses.
Tanaka Y, Takahashi K, Orito E, Karino Y, Kang JH, Suzuki K, Matsui A, Hori A, Matsuda H, Sakugawa H, Asahina Y, Kitamura T, Mizokami M, Mishiro S. Tanaka Y, et al. Among authors: sakugawa h. J Gen Virol. 2006 Apr;87(Pt 4):949-954. doi: 10.1099/vir.0.81661-0. J Gen Virol. 2006. PMID: 16528044
101 results